Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y)
2024-510787-23-00Phase 4Completed
- Sponsor
- Varsinais-Suomen hyvinvointialue
- Start
- Apr 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of diphtheria and tetanus toxoids and acellular pertussis-inactivated poliovirus vaccine in pertussis (2 arms), sponsored by Varsinais-Suomen hyvinvointialue. Primary endpoint: PT-specific IgG GMC at 4 years + 28 days. Started Apr 2024; status: completed.
02
Drugs
diphtheria and tetanus toxoids and acellular pertussis-inactivated poliovirus vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on 2024-510787-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510787-23-00.